You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 2, February 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The role of photocoagulation in the management of retinoblastoma

J. A. Shields, C. L. Shields, H. Parsons and M. E. Giblin
Ocular Oncology Service, Wills Eye Hospital, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107.

We treated selected patients with retinoblastoma with xenon arc photocoagulation between February 1974 and August 1987. Of 790 individual tumors in 410 affected eyes, 45 were treated by this technique. Overall photocoagulation alone was successful in eradicating 76% of the tumors, while in 24% of the tumors additional treatment with cryotherapy, plaque radiotherapy, external beam radiotherapy, or enucleation was necessary. In cases where the tumor was less than or equal to 3.0 mm in diameter and 2.0 mm in thickness and was confined to the sensory retina, without seeding into the adjacent vitreous, tumor destruction was achieved with photocoagulation. The mean number of photocoagulation sessions needed for complete tumor regression was 2.5. Photocoagulation alone was generally unsuccessful for tumors greater than 4.5 mm in diameter and 2.5 mm in thickness, and supplemental treatment with other modalities was often necessary in such cases. Based on observations in these patients, we point out certain misconceptions regarding photocoagulation of retinoblastomas and define our current indications and contraindications for this treatment modality.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinoblastoma: Review of Current Management
Chintagumpala et al.
The Oncologist 2007;12:1237-1246.
ABSTRACT | FULL TEXT  

High resolution magnetic resonance imaging of retinoblastoma
Schueler et al.
Br. J. Ophthalmol. 2003;87:330-335.
ABSTRACT | FULL TEXT  

Thermochemotherapy in hereditary retinoblastoma
Schueler et al.
Br. J. Ophthalmol. 2003;87:90-95.
ABSTRACT | FULL TEXT  

Intraocular Surgery After Treatment of Retinoblastoma
Honavar et al.
Arch Ophthalmol 2001;119:1613-1621.
ABSTRACT | FULL TEXT  

First-Line Chemotherapy With Local Treatment Can Prevent External-Beam Irradiation and Enucleation in Low-Stage Intraocular Retinoblastoma
Beck et al.
JCO 2000;18:2881-2887.
ABSTRACT | FULL TEXT  

Importance of early diagnosis of retinoblastoma
SHIELDS
Br. J. Ophthalmol. 1999;83:1315-1316.
FULL TEXT  

Utility of Pupillary Dilation for Detecting Leukocoria in Patients With Retinoblastoma
Canzano and Handa
Pediatrics 1999;104:44e-44.
ABSTRACT | FULL TEXT  

Thermotherapy for Retinoblastoma
Shields et al.
Arch Ophthalmol 1999;117:885-893.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.